Japan

Rentschler strengthens Japanese ties with Summit Pharmaceuticals

The East Asian country is the world’s third largest pharmaceuticals market.

Rentschler strengthens Japanese ties with Summit Pharmaceuticals

The East Asian country is the world’s third largest pharmaceuticals market.

Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b

The pharma will assume ownership interests in five biopharma companies.

Pricing reforms threaten pharma investment in Japan

Fewer companies may enjoy full benefit of the premium under the new requirements.

Japan to build 10 AI-based hospitals by 2022

It plans to invest more than $100m to tackle the lack of medical personnel and rise in medical expenses.

Japan's pharmaceutical growth hampered by pricing pressures: Fitch Solutions

Sales are expected to fall 30% to US$62b by 2025 once the new annual price review takes effect.

Malaysia's Sime Darby eyes healthcare portfolio expansion

It targets to go beyond other markets within the region.

Japan banks on big data solutions to keep healthcare costs in check

It eyes to employ AI and robots at long-term care facilities to help caregivers.

Japan's healthcare expenditure hits all-time high of $36b in 2017

This is due to demand for costly anti-cancer drugs.

Japan to build AI hospitals amidst doctor shortage

It could gear up manufacturers to develop more advanced equipment.

Japan eyes record budget to boost welfare spending

But the retirement age may soon be raised.

Japan to remain Asia-Pacific's most attractive pharmaceuticals market

Despite a pricing regime that limits revenue-generation opportunities for companies.